A 48-year-old woman with primary biliary cholangitis (PBC) has progressed to cirrhosis. Regarding the histopathological features and complications of cirrhosis, all of the following are characteristic findings EXCEPT:

Explanation

## Histopathology and Classification of Cirrhosis ### Structural Features of Cirrhosis **Key Point:** Cirrhosis is characterized by diffuse hepatic fibrosis with loss of normal architecture, formation of regenerative nodules, and bridging fibrosis. The nodule size and etiology determine the classification, but both micronodular and macronodular cirrhosis can progress at variable rates. ### Histopathological Features (All Correct Except One) | Feature | Description | Significance | |---------|-------------|-------------| | **Regenerative nodules** | Hepatocyte proliferation within fibrous septa; may be micro (<3 mm) or macro (>3 mm) | Hallmark of cirrhosis; reflects hepatocyte regeneration | | **Bridging fibrosis** | Fibrous septa connecting portal-to-portal (P-P), portal-to-central (P-C), and central-to-central (C-C) tracts | Architectural distortion; defines cirrhosis | | **Micronodular cirrhosis** | Nodules <3 mm; common in alcoholic liver disease, HBV, and HCV | Often associated with active inflammation | | **Macronodular cirrhosis** | Nodules >3 mm; seen in HCV, HBV, and PBC | May have slower progression; variable outcome | [cite:Robbins 10e Ch 18] ### Why the Incorrect Statement Is Wrong **High-Yield:** The statement that macronodular cirrhosis is **always irreversible and progresses to hepatic failure within 2 years** is **too absolute and incorrect**. **Clinical Pearl:** The prognosis of cirrhosis depends on: 1. **Etiology** (HCV with viral clearance may stabilize; alcoholic cirrhosis with continued drinking progresses rapidly) 2. **Degree of inflammation** (active cirrhosis progresses faster than inactive) 3. **Presence of complications** (variceal bleeding, hepatic encephalopathy, renal failure worsen prognosis) 4. **Nodule size is NOT a reliable predictor of progression rate** Macronodular cirrhosis can remain stable for years with appropriate management, or progress rapidly depending on the underlying cause and patient factors. The 2-year timeline is arbitrary and not supported by evidence. **Mnemonic: CHILD-Pugh Score** — **C**omprehen**H**ensive **I**nternational **L**iver **D**isease scoring uses bilirubin, albumin, INR, ascites, and encephalopathy (not nodule size) to predict prognosis. ### Micronodular vs. Macronodular Cirrhosis ```mermaid flowchart TD A[Cirrhosis]:::outcome --> B{Nodule Size}:::decision B -->|< 3 mm| C[Micronodular]:::outcome C --> D[Alcoholic liver disease<br/>HBV, HCV<br/>Active inflammation]:::action B -->|> 3 mm| E[Macronodular]:::outcome E --> F[HCV, HBV, PBC<br/>Chronic cholestasis<br/>Variable progression]:::action D --> G[Prognosis depends on<br/>etiology & inflammation<br/>NOT nodule size alone]:::action F --> G ``` **Warning:** Do not assume that macronodular cirrhosis has a fixed poor prognosis. Prognosis is multifactorial and requires clinical assessment, not histological classification alone. [cite:Robbins 10e Ch 18]